Phase I-II study of intravenous BCX-1777 [forodesine] in relapsed or refractory aggressive (high grade) T-cell malignancies
Latest Information Update: 26 Jul 2007
At a glance
- Drugs Forodesine (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 06 Sep 2005 New trial record.